LP
LCTX icon

LMR Partners’s Lineage Cell Therapeutics LCTX Stock Holding History

LMR Partners’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.4K Buy
+21,160
New +$35.7K ﹤0.01% 1329
2023
Q2 		– Sell
-83,395
Closed -$125K – 1029
2023
Q1 		$125K Buy
+83,395
New +$116K ﹤0.01% 914
2022
Q4 		– Sell
-44,733
Closed -$51K – 1201
2022
Q3 		$51K Hold
44,733
– – ﹤0.01% 1097
2022
Q2 		$71K Buy
+44,733
New +$59K ﹤0.01% 1125
2021
Q2 		– Sell
-72,194
Closed -$170K – 1235
2021
Q1 		$170K Buy
+72,194
New +$173K ﹤0.01% 809
2020
Q4 		– Sell
-40,083
Closed -$38K – 568
2020
Q3 		$38K Sell
40,083
-7,074
-15% -$6.25K ﹤0.01% 400
2020
Q2 		$41K Buy
+47,157
New +$41.5K ﹤0.01% 537
2015
Q2 		– Sell
-22,658
Closed -$91K – 576
2015
Q1 		$91K Buy
+22,658
New +$78.4K 0.01% 375

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return